Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-012405

Head of Pharm Ops and Tech gave up 117 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 240 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2024-04-01 Option exercise +240 9,751.37 D: show line 1 in the form
Murphy Nicole Head of Pharm Ops and Tech 2024-04-01 Shares withheld for taxes −117 $214.83 $25,135 9,634.37 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Murphy Nicole Head of Pharm Ops and Tech 2024-04-01 Option exercise · Restricted Stock Unit −240 0 D: show line 3 in the form
Loading xslF345X05/form4.xml…